NCT03209115

Brief Summary

Influence of Calcium hydroxide Chlorhexidine Combination vs. Calcium Hydroxide as an Intra canal Medicamentson Postoperative flare -up following two-Visit Endodontic Retreatment cases

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at P25-P50 for early_phase_1

Timeline
Completed

Started Jul 2017

Shorter than P25 for early_phase_1

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 3, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 6, 2017

Completed
2 days until next milestone

Study Start

First participant enrolled

July 8, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 8, 2017

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 8, 2018

Completed
Last Updated

July 6, 2017

Status Verified

July 1, 2017

Enrollment Period

2 months

First QC Date

July 3, 2017

Last Update Submit

July 5, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative flare up (pain and swelling ) will be measured as below after 7 days from first visit postoperative pain

    categorical ( 4 points) 1. no pain 2. Mild pain: recognizable but not discomforting pain that required no analgesics. 3. Moderate pain: discomforting but bearable pain(analgesics if used were effective in relieving pain) 4. Severe pain: difficult to bear (analgesics were effective in relieving pain). Patients with severe postoperative pain and/or occurrence of swelling were classified as flare-ups.3 Objectively : percussion test

    7 days

Study Arms (2)

calcium hydroxide and chlorhexidine

ACTIVE COMPARATOR

Removal of old root canal filling and placing calcium hydroxide and chlorehexidine as intracanal medication

Drug: combination of calcium hydroxide and chlorhexidine

calcium hydroxide

ACTIVE COMPARATOR

Removal of old root canal filling and placing calcium hydroxide as intracanal medication

Drug: Calcium Hydroxide

Interventions

placement of calcium hydroxide and chlorhexidine as intracanal medicament after removal of old filling and mechanical preparation of root canal

calcium hydroxide and chlorhexidine

placement of calcium hydroxide as intracanal medicament after removal of old filling and mechanical preparation of root canal

calcium hydroxide

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients' needs retreatment.
  • Patients in good health with no systemic disease (American Society of Anesthesiologists Class II)
  • Age range is between 20 and 50 years.
  • Patients who can understand the categorical tool (points)for measurement
  • Patients able to sign informed consent.

You may not qualify if:

  • Complicating systemic disease
  • Having severe pain and/or acute apical abscesses
  • Being under 18 years of age
  • Using antibiotics or corticosteroids

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

ChlorhexidineCalcium Hydroxide

Intervention Hierarchy (Ancestors)

BiguanidesGuanidinesAmidinesOrganic ChemicalsHydroxidesAlkaliesInorganic ChemicalsCalcium CompoundsAnionsIonsElectrolytes

Study Officials

  • Geraldine M Ahmed, Assistant professor

    Cairo University

    STUDY DIRECTOR

Central Study Contacts

Hind Midhat Abdul Gader, bachelor

CONTACT

Hanaa Midhat Abdul Gader, bachelor

CONTACT

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Intracanal medication
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

July 3, 2017

First Posted

July 6, 2017

Study Start

July 8, 2017

Primary Completion

September 8, 2017

Study Completion

July 8, 2018

Last Updated

July 6, 2017

Record last verified: 2017-07

Data Sharing

IPD Sharing
Will not share